B-type Natriuretic Peptide Before Discharge after Left Ventricular Assist Device Implantation Is Associated With Subsequent Hospitalization due to Cardiac Causes

Background: Although the level of B-type natriuretic peptide (BNP) before discharge is a well-known predictor for prognosis among chronic heart failure patients, its impact on patients with implantable left ventricular assist device (iLVAD) is still uncertain. Methods: Those who received iLVAD implantation between 2008 and 2016 in our institute and have been followed up for>1 year were enrolled. Those who were converted from extracorporeal VAD, who deceased, or received heart transplantation within 1 year after iLVAD implantation were excluded.

Source: Journal of Cardiac Failure - September 20, 2017 Category: Cardiology Authors: Daisuke Nitta, Koichiro Kinugawa, Eisuke Amiya, Masaru Hatano, Osamu Kinoshita, Kan Nawata, Minoru Ono, Issei Komuro Source Type: research